Evidence map›Paper›PMID 35631349›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Development and Validation of Analytical Methods for Radiochemical Purity of

Pauline Orhon, Marie-Dominique Desruet, Marie Piquemal, Nicolas De Leiris, Loïc Djaileb, Jean-Philippe Vuillez, Pierrick Bedouch, Julien Leenhardt

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. GMP-compliant automated synthesis and quality control of [EJNMMI radiopharmacy and chemistry · 2026
    Article
  2. Improved quality control of [EJNMMI radiopharmacy and chemistry · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Pauline OrhonPharmacy Department, Grenoble Alpes University Hospital, 38000 Grenoble, France.ORCID 0000-0002-7212-4796
Marie-Dominique DesruetPharmacy Department, Grenoble Alpes University Hospital, 38000 Grenoble, France.
Marie PiquemalPharmacy Department, Grenoble Alpes University Hospital, 38000 Grenoble, France.
Nicolas De LeirisLRB, CHU Grenoble Alpes, INSERM, Grenoble Alpes University, 38000 Grenoble, France.ORCID 0000-0002-0145-259X
Loïc DjailebLRB, CHU Grenoble Alpes, INSERM, Grenoble Alpes University, 38000 Grenoble, France.
Jean-Philippe VuillezLRB, CHU Grenoble Alpes, INSERM, Grenoble Alpes University, 38000 Grenoble, France.
Pierrick BedouchPharmacy Department, Grenoble Alpes University Hospital, 38000 Grenoble, France.
Julien LeenhardtPharmacy Department, Grenoble Alpes University Hospital, 38000 Grenoble, France.ORCID 0000-0002-2863-5011
Inserm · FRUniversité Grenoble Alpes · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate Specific Membrane Antigen (PSMA) is a highly relevant target in nuclear medicine due to its overexpression in prostate cancer. The

Indexed as

177Lu-PSMA-1high-performance liquid chromatography (HPLC)prostate cancerradiochemical purityradioligand therapythin-layer chromatography (TLC)validation of analytical methods

Identifiers

PMID35631349
PMCPMC9143309
OpenAlexW4224319536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.